Atlas Trials

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Clinical trial NCT01336920 · COMPLETED

Trial details

NCT number
NCT01336920
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaPeripheral T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma
Start date
2011-06-21
Primary completion
2015-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.